Report Summary: Point of care (POC) technologies are rapidly becoming part of the revolution of the healthcare landscape. With evolving high–tech innovations in healthcare, including smartphone apps, biosensors, lab–on–a chip, and wearable devices—all of which offer a closer connection to the patient. The dynamic of point of–care testing (POCT) is to bring testing closer to the patient and results conveniently and quickly to the provider to expedite diagnosis and subsequent treatment. POCT allows for faster clinical decisions in hospitals, physicians’ offices, ambulances, patient homes, and in the field. The global point of care testing market is projected to reach US$ 38 Billion by 2022, at a CAGR of XX% from 2016 to 2022. The global market is mainly driven by increasing prevalence of infectious diseases in developing countries, the rising incidences of lifestyle diseases such as cardiac diseases and diabetes, the rising usage of home–based POC devices, and ...